US Stock MarketDetailed Quotes

Rocket Pharmaceuticals (RCKT)

Watchlist
  • 3.250
  • -0.150-4.41%
Close May 15 16:00 ET
  • 3.270
  • +0.020+0.62%
Post 19:34 ET
354.88MMarket Cap-1.74P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Rocket Pharmaceuticals (RCKT) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-24.66%48.51M
-16.36%228.52M
-29.77%44.03M
-24.49%52.42M
-8.19%67.68M
-4.43%64.39M
5.22%273.21M
-0.92%62.69M
6.11%69.42M
7.21%73.71M
Selling and administrative expenses
-40.04%17.06M
-15.16%86.5M
-42.05%14.68M
-32.31%18.35M
-8.58%25.02M
28.44%28.45M
39.07%101.96M
17.65%25.34M
45.86%27.11M
57.52%27.37M
-General and administrative expense
-40.04%17.06M
-15.16%86.5M
-42.05%14.68M
-32.31%18.35M
-8.58%25.02M
28.44%28.45M
39.07%101.96M
17.65%25.34M
45.86%27.11M
57.52%27.37M
Research and development costs
-12.49%31.45M
-17.07%142.02M
-21.44%29.35M
-19.49%34.07M
-7.96%42.66M
-20.53%35.94M
-8.10%171.24M
-10.51%37.36M
-9.67%42.32M
-9.80%46.35M
Operating profit
24.66%-48.51M
16.36%-228.52M
29.77%-44.03M
24.49%-52.42M
8.19%-67.68M
4.43%-64.39M
-5.22%-273.21M
0.92%-62.69M
-6.11%-69.42M
-7.21%-73.71M
Net non-operating interest income expense
-69.97%917K
-40.36%8.62M
-39.80%1.43M
-29.21%1.92M
-45.15%2.23M
-42.60%3.05M
2.81%14.46M
-34.60%2.37M
-23.37%2.71M
33.05%4.07M
Non-operating interest income
-60.58%1.39M
-35.67%10.52M
-33.17%1.9M
-24.81%2.39M
-40.42%2.7M
-39.12%3.53M
2.55%16.35M
-30.55%2.84M
-20.58%3.18M
28.75%4.54M
Non-operating interest expense
0.21%473K
0.27%1.89M
0.00%473K
0.42%473K
0.42%473K
0.21%472K
0.59%1.89M
0.64%473K
0.43%471K
0.64%471K
Other net income (expense)
-3.23M
68K
172K
-3.47M
Special income (charges)
----
---3.23M
--68K
--172K
---3.47M
----
--0
--0
--0
--0
-Less：Restructuring and merger&acquisition
----
--3.23M
---68K
---172K
--3.47M
----
--0
--0
--0
--0
Income before tax
22.40%-47.59M
13.77%-223.12M
29.49%-42.54M
24.56%-50.33M
1.04%-68.92M
1.16%-61.33M
-5.35%-258.75M
-1.12%-60.33M
-7.79%-66.72M
-6.00%-69.65M
Income tax
Net income
22.40%-47.59M
13.77%-223.12M
29.49%-42.54M
24.56%-50.33M
1.04%-68.92M
1.16%-61.33M
-5.35%-258.75M
-1.12%-60.33M
-7.79%-66.72M
-6.00%-69.65M
Net income continuous Operations
22.40%-47.59M
13.77%-223.12M
29.49%-42.54M
24.56%-50.33M
1.04%-68.92M
1.16%-61.33M
-5.35%-258.75M
-1.12%-60.33M
-7.79%-66.72M
-6.00%-69.65M
Minority interest income
Net income attributable to the parent company
22.40%-47.59M
13.77%-223.12M
29.49%-42.54M
24.56%-50.33M
1.04%-68.92M
1.16%-61.33M
-5.35%-258.75M
-1.12%-60.33M
-7.79%-66.72M
-6.00%-69.65M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
22.40%-47.59M
13.77%-223.12M
29.49%-42.54M
24.56%-50.33M
1.04%-68.92M
1.16%-61.33M
-5.35%-258.75M
-1.12%-60.33M
-7.79%-66.72M
-6.00%-69.65M
Basic earnings per share
25.00%-0.42
26.37%-2.01
38.71%-0.38
36.62%-0.45
16.22%-0.62
15.15%-0.56
6.51%-2.73
3.13%-0.62
5.33%-0.71
9.76%-0.74
Diluted earnings per share
25.00%-0.42
26.37%-2.01
38.71%-0.38
36.62%-0.45
16.22%-0.62
15.15%-0.56
6.51%-2.73
3.13%-0.62
5.33%-0.71
9.76%-0.74
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -24.66%48.51M-16.36%228.52M-29.77%44.03M-24.49%52.42M-8.19%67.68M-4.43%64.39M5.22%273.21M-0.92%62.69M6.11%69.42M7.21%73.71M
Selling and administrative expenses -40.04%17.06M-15.16%86.5M-42.05%14.68M-32.31%18.35M-8.58%25.02M28.44%28.45M39.07%101.96M17.65%25.34M45.86%27.11M57.52%27.37M
-General and administrative expense -40.04%17.06M-15.16%86.5M-42.05%14.68M-32.31%18.35M-8.58%25.02M28.44%28.45M39.07%101.96M17.65%25.34M45.86%27.11M57.52%27.37M
Research and development costs -12.49%31.45M-17.07%142.02M-21.44%29.35M-19.49%34.07M-7.96%42.66M-20.53%35.94M-8.10%171.24M-10.51%37.36M-9.67%42.32M-9.80%46.35M
Operating profit 24.66%-48.51M16.36%-228.52M29.77%-44.03M24.49%-52.42M8.19%-67.68M4.43%-64.39M-5.22%-273.21M0.92%-62.69M-6.11%-69.42M-7.21%-73.71M
Net non-operating interest income expense -69.97%917K-40.36%8.62M-39.80%1.43M-29.21%1.92M-45.15%2.23M-42.60%3.05M2.81%14.46M-34.60%2.37M-23.37%2.71M33.05%4.07M
Non-operating interest income -60.58%1.39M-35.67%10.52M-33.17%1.9M-24.81%2.39M-40.42%2.7M-39.12%3.53M2.55%16.35M-30.55%2.84M-20.58%3.18M28.75%4.54M
Non-operating interest expense 0.21%473K0.27%1.89M0.00%473K0.42%473K0.42%473K0.21%472K0.59%1.89M0.64%473K0.43%471K0.64%471K
Other net income (expense) -3.23M68K172K-3.47M
Special income (charges) -------3.23M--68K--172K---3.47M------0--0--0--0
-Less：Restructuring and merger&acquisition ------3.23M---68K---172K--3.47M------0--0--0--0
Income before tax 22.40%-47.59M13.77%-223.12M29.49%-42.54M24.56%-50.33M1.04%-68.92M1.16%-61.33M-5.35%-258.75M-1.12%-60.33M-7.79%-66.72M-6.00%-69.65M
Income tax
Net income 22.40%-47.59M13.77%-223.12M29.49%-42.54M24.56%-50.33M1.04%-68.92M1.16%-61.33M-5.35%-258.75M-1.12%-60.33M-7.79%-66.72M-6.00%-69.65M
Net income continuous Operations 22.40%-47.59M13.77%-223.12M29.49%-42.54M24.56%-50.33M1.04%-68.92M1.16%-61.33M-5.35%-258.75M-1.12%-60.33M-7.79%-66.72M-6.00%-69.65M
Minority interest income
Net income attributable to the parent company 22.40%-47.59M13.77%-223.12M29.49%-42.54M24.56%-50.33M1.04%-68.92M1.16%-61.33M-5.35%-258.75M-1.12%-60.33M-7.79%-66.72M-6.00%-69.65M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 22.40%-47.59M13.77%-223.12M29.49%-42.54M24.56%-50.33M1.04%-68.92M1.16%-61.33M-5.35%-258.75M-1.12%-60.33M-7.79%-66.72M-6.00%-69.65M
Basic earnings per share 25.00%-0.4226.37%-2.0138.71%-0.3836.62%-0.4516.22%-0.6215.15%-0.566.51%-2.733.13%-0.625.33%-0.719.76%-0.74
Diluted earnings per share 25.00%-0.4226.37%-2.0138.71%-0.3836.62%-0.4516.22%-0.6215.15%-0.566.51%-2.733.13%-0.625.33%-0.719.76%-0.74
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +34.01%
Sample Name
Sample Code
 +27.74%
Sample Name
Sample Code
 +26.87%
4
United States Gasoline Fund Lp
UGA
+26.33%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+20.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.54%
Sample Name
Sample Code
 +10.70%
Sample Name
Sample Code
 +6.24%
4
NIO Inc
NIO
+4.27%
5
Hesai
HSAI
+3.89%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -